News & Events

Interviews

Manel González-Piñero

Headof Innovation at CREB UPC and XarTEC SALUT

"Our main objectives are to develop a technologies map of the members of XarTEC SALUT and to find the most effective ways to support them."

The Research Centre for Biomedical Engineering (CREB) at the UPC, an institution affiliated with the Institut de Recerca Sant Joan de Déu (IRSJD), received top funding in 2020 from the European Regional Development Fund (ERDF), under the management of the Government of Catalonia, to create and coordinate XarTEC SALUT, Catalonia's first health technologies innovation and valorisation network.
  1. César Galo Garcia Fontecha

    Head of the Orthopaedic Surgery and Traumatology Group

    “Learning about what others are doing allows us to improve and develop new ideas in order to advance in the world of research.”

    In 2022, the research team led by Dr. César Galo Garcia Fontecha joined the Sant Joan de Déu Research Institute as the “Orthopaedic Surgery and Traumatology” Group. We take a look at his scientific career up to the time he joined SJD Barcelona Children’s Hospital and the objectives of his new group.
    Doctor César Galo Garcia Fontecha
  2. Judith Armstrong

    Group leader · Genomics for the diagnosis of rare diseases

    "All the researchers on the team know that families and patients are a key part of our research, and we need to be able to pass on what we do."

    Dra. Judith Armstrong recently consolidated her research on minority diseases at the Institut de Recerca Sant Joan de Déu with the creation of the new group "Genomics for the diagnosis of rare diseases"
  1. Alexandra Avgustinova

    Group leader · Paediatric Tumour Epigenetics Group

    “We approach the study of paediatric tumours from different angles with the ultimate goal of developing more personalised and less aggressive treatments”

    Dr Alexandra Avgustinova joined the Institut de Recerca Sant Joan de Déu (IRSJD) at the end of 2020.

  2. Montse Gil

    Researcher

    "Whether or not to start a new drug treatment should be an informed and shared decision made jointly by the prescriber and the patient."

    Dr Montse Gil, a member of the research group Assessment of Health Technologies in Primary Care and Mental Health (PRISMA), has just presented her doctoral thesis, "The Problem of Non-Initiation of Drug Treatment: Assessment with Qualitative Methods", where she analyses why patients decide not to initiate a new pharmacological treatment.

  3. Dr. Martín Iriondo

    Group leader

    “The goal of our research is to reduce the morbidity of newborn babies with problems and improve their long-term development.”

    It can be rightly said that the driving force behind the research carried out by the Neonatology Department at the Sant Joan de Déu Barcelona Children's Hospital was Dr Xavier Krauel, who laid the first stone of what is now the Neonatology Research Group at the Sant Joan de Déu Research Institute (IRSJD), led by Dr Martín Iriondo, the current head of the department.

  4. Sara Siddi

    Researcher

    "For us patient participation is crucial to developing the project and improving their quality of life in the future."

    Dr Sara Siddi from the Sant Joan de Déu Research Institute · Sant Joan de Déu Health Park is a member of the RADAR-CNS European project, which was launched in 2016 and will end in March 2022. The project has already recruited more than 400 participants from around Europe suffering from depression

  5. The discovery of GDF15 overexpression in patients with mitochondrial disease opened a door towards an improvement in their diagnosis

    Dr. Ceciclia Jiménez-Mallebrera leads a translational research team focused on childhood neuromuscular diseases. Her laboratory works with the Neuromuscular Unit, Neuropaediatrics Service, at the Hospital Sant Joan de Déu (HSJD). They work together to improve the diagnosis and treatment of these diseases, with the goal of improving the quality of life of the affected children.